Literature DB >> 18825433

Orbital apex lesion due to Aspergillosis presenting in immunocompetent patients without apparent sinus disease.

L O'Toole1, J A Acheson, D Kidd.   

Abstract

We present two cases in which Aspergillus infection was identified at a late stage in the clinical evaluation as the cause for a painful, progressive and indolent orbital apex syndrome in the absence of any clinical or radiological sign of sinus involvement. Surgical investigation was undertaken with serious subsequent morbidity. Although treatment is often satisfactory, neurological outcome is without exception poor. A review of the literature has revealed that the risk of such investigations is high, and advice is provided to readers which may allow avoidance of such complications in the future.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18825433     DOI: 10.1007/s00415-008-0977-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  10 in total

1.  Aspergillosis causing bilateral optic neuritis and later orbital apex syndrome.

Authors:  Toshihiko Matsuo; Kenji Notohara; Ichiro Yamadori
Journal:  Jpn J Ophthalmol       Date:  2005 Sep-Oct       Impact factor: 2.447

2.  Compressive optic neuropathy in fungal hypertrophic cranial pachymeningitis.

Authors:  A R Ismail; L Clifford; W R Meacock
Journal:  Eye (Lond)       Date:  2006-12-15       Impact factor: 3.775

3.  Parasellar and orbital apex syndrome caused by aspergillosis.

Authors:  T R Hedges; L S Leung
Journal:  Neurology       Date:  1976-02       Impact factor: 9.910

4.  Aspergillosis related to long-term nasal corticosteroid use.

Authors:  Robert L Bratton; Paul W Brazis; Walter C Hellinger; Robert E Wharen; Daniel F Broderick
Journal:  Mayo Clin Proc       Date:  2002-12       Impact factor: 7.616

5.  Aspergillus fumigatus infection of the optic nerve with mycotic arteritis of cerebral vessels.

Authors:  S S Fernando; C S Lauer
Journal:  Histopathology       Date:  1982-03       Impact factor: 5.087

6.  Successful treatment of invasive cavernous sinus aspergillosis with oral itraconazole monotherapy.

Authors:  Andrew C Browning; Kuan T Sim; Judith M Timms; Stephen A Vernon; Norman S McConachie; Richard Allibone; Nick S Jones
Journal:  J Neuroophthalmol       Date:  2006-06       Impact factor: 3.042

7.  Aspergillosis of ethmoid sinus and optic nerve, with arteritis and rupture of the internal carotid artery.

Authors:  N Corvisier; F Gray; R Gherardi; F Lebras; C M Blanc; J P Nguyen; J Poirier
Journal:  Surg Neurol       Date:  1987-10

8.  Optic neuropathy and paratrigeminal syndrome due to Aspergillus fumigatus.

Authors:  J M Weinstein; F A Sattler; J Towfighi; J Sassani; R B Page
Journal:  Arch Neurol       Date:  1982-09

9.  Concurrent sino-orbital aspergillosis and cerebral nocardiosis.

Authors:  Liselotte Pieroth; Jacqueline M S Winterkorn; Hermann Schubert; William S Millar; Michael Kazim
Journal:  J Neuroophthalmol       Date:  2004-06       Impact factor: 3.042

10.  Neuro-ophthalmological presentation of non-invasive Aspergillus sinus disease in the non-immunocompromised host.

Authors:  P Brown; P Demaerel; A McNaught; T Revesz; E Graham; B E Kendall; G Plant
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-02       Impact factor: 10.154

  10 in total
  3 in total

1.  Aspergillus osteomyelitis of the lumbar spine complicated with orbital apex syndrome: A potential role of the Batson's plexus in disease propagation.

Authors:  Jose F Camargo; Vimon Seriburi; Michael Tenner; Marc Y El Khoury
Journal:  Med Mycol Case Rep       Date:  2012-03-15

2.  A congruous superior quadrantanopsia following a junctional scotoma induced by asperogillosis.

Authors:  In Ki Park; Seok Hyun Lee; Yeoun Sook Chun
Journal:  Korean J Ophthalmol       Date:  2011-07-22

3.  Orbital apex syndrome due to aspergillosis with subsequent fatal subarachnoid hemorrhage.

Authors:  Chi-Man Yip; Shu-Shong Hsu; Wei-Chuan Liao; Jun-Yih Chen; Su-Hao Liu; Chih-Hao Chen
Journal:  Surg Neurol Int       Date:  2012-10-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.